Purine nucleoside and nucleobase transporters are of fundamental importance for Trypanosoma brucei and related kinetoplastid parasites because these protozoa are not able to synthesize purines de novo and must salvage the compounds from their hosts. In the studies reported here, we have identified a family of six clustered genes in T. brucei that encode nucleoside/nucleobase transporters. These genes, TbNT2/927, TbNT3, TbNT4, TbNT5, TbNT6, and TbNT7, have predicted amino acid sequences that show high identity to each other and to TbNT2, a P1 type nucleoside transporter recently identified in our laboratory. Expression in Xenopus laevis oocytes revealed that TbNT2/927, TbNT5, TbNT6, and TbNT7 are high affinity adenosine/inosine transporters with K m values of <5 M. In addition, TbNT5, and to a limited degree TbNT6 and TbNT7, also mediate the uptake of the nucleobase hypoxanthine. Ribonuclease protection assays showed that mRNA from all of the six members of this gene family are expressed in the bloodstream stage of the T. brucei life cycle but that TbNT2/927 and TbNT5 mRNAs are also expressed in the insect stage of the life cycle. These results demonstrate that T. brucei expresses multiple purine transporters with distinct substrate specificities and different patterns of expression during the parasite life cycle.African trypanosomes are of considerable medical and economic importance because they cause a debilitating disease in humans (sleeping sickness) and livestock (nagana) throughout a large portion of sub-Saharan Africa (1). These parasites have a digenetic life cycle, with two main stages: the bloodstream form (BF) 1 that lives in the bloodstream of its mammalian host and the procyclic form (PF) that lives in the insect vector (tsetse fly). Purines are essential for the growth, multiplication, and survival of these organisms because the parasites are incapable of synthesizing the purine ring de novo (2, 3). Furthermore, nucleoside/nucleobase transporters are of considerable pharmacological importance, because both purine analogs and nonpurine analog drugs are taken up by some of these permeases, and loss of permease function can lead to drug resistance (4, 5).Two different nucleoside transport systems have been characterized in intact Trypanosoma brucei cells. The P1 type system mediates the uptake of purine nucleosides (adenosine, inosine, and guanosine) and is detected in both BF and PF life cycle stages, and the P2 type system mediates the uptake of adenosine and adenine, as well as several anti-trypanosomal drugs, and is detected only in the BF (6, 7) parasites. In addition, four nucleobase transport activities have also been identified. H1, H2, and H3 mediate the transport of hypoxanthine, guanine, and adenine (8, 9). H1 activity is found in PF, and H2 and H3 activities are found in BF. In addition, the U1 activity mediates the transport of uracil in PFs (10). However, meticulous functional and biochemical characterization of these transporters at the molecular level is needed to understand the biol...